Article
Dallas-Essilor Laboratories of America will add about $7 million in annual sales to its totals with the purchase of the assets of three laboratories in Phoenix, Tucson, and Denver.
Strabismus in animation: study highlights harmful stereotypes in children's films
ROP: Treating and preventing blindness in preterm babies
NIH highlights 5 key elements of cortical visual impairment (CVI)
Managing a changing landscape of IRD pediatric cases
Cerebral visual impairment is a growing concern in pediatric vision loss
Study explores the true costs of treating pediatric cataracts